RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Common genetic variants in 11q13.3 and 9q22.33 are associated with molecular subgroups of multiple myeloma
Erickson, S., Stephens, O., Chavan, S., Tian, E., Epstein, J., Barlogie, B., Heuck, C., & Vangsted, A. (2015). Common genetic variants in 11q13.3 and 9q22.33 are associated with molecular subgroups of multiple myeloma. Leukemia, 29(12), 2418-2421. https://doi.org/10.1038/leu.2015.238
Recently, Weinhold et al.1 reported the association of a potentially functional single-nucleotide polymorphism (SNP) in the CCND1 gene with an increased incidence of t(11;14) in multiple myeloma (MM). MM can be classified by gene expression profiling (GEP) into seven well-defined molecular subgroups, of which four are strongly influenced by specific translocations involving the immunoglobulin heavy chain locus. These translocations are characterized by transcriptional activation of the genes CCND1 [t(11;14)(q13;q32)], CCND3 [t(6;14)(p21;q32)], c-MAF [t(14;16)(q32;q23)], MAFB [t(14;20)(q32;q11)] and FGFR3/MMSET [t(4;14)(q16;q32)].